tetano
Editor, Senior Moderator
Vaccine. 2019 Apr 23. pii: S0264-410X(19)30511-0. doi: 10.1016/j.vaccine.2019.04.047. [Epub ahead of print]
[h=1]Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.[/h] Xeuatvongsa A[SUP]1[/SUP], Mott JA[SUP]2[/SUP], Khanthamaly V[SUP]3[/SUP], Patthammavong C[SUP]1[/SUP], Phounphenghak K[SUP]1[/SUP], McKinlay M[SUP]4[/SUP], Mirza S[SUP]5[/SUP], Lafond KE[SUP]5[/SUP], McCarron M[SUP]5[/SUP], Corwin A[SUP]6[/SUP], Moen A[SUP]5[/SUP], Olsen SJ[SUP]5[/SUP], Bresee JS[SUP]7[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Despite global recommendations for influenza vaccination of high-risk, target populations, few low and middle-income countries have national influenza vaccination programs. Between 2012 and 2017, Lao PDR planned and conducted a series of activities to develop its national influenza vaccine program as a part of its overall national immunization program. In this paper, we review the underlying strategic planning for this process, and outline the sequence of activities, research studies, partnerships, and policy decisions that were required to build Laos' influenza vaccine program. The successful development and sustainability of the program in Laos offers lessons for other low and middle-income countries interested in initiating or expanding influenza immunization.
Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza; Laos; Policy; Vaccination program; Vaccine
PMID: 31027926 DOI: 10.1016/j.vaccine.2019.04.047
[TABLE="cellspacing: 1"]
[TR]
[TD="class: SL, width: 10%, align: right"][/TD]
[TD="class: SL, width: 20%, align: left"]Detect languageundefined[/TD]
[TD="class: SL, width: 3, align: center"]
[/TD]
[TD="class: SL, width: 20%, align: left"]undefined[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 15%, align: right"]
[/TD]
[/TR]
[/TABLE]
Text-to-speech function is limited to 200 characters
[h=1]Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.[/h] Xeuatvongsa A[SUP]1[/SUP], Mott JA[SUP]2[/SUP], Khanthamaly V[SUP]3[/SUP], Patthammavong C[SUP]1[/SUP], Phounphenghak K[SUP]1[/SUP], McKinlay M[SUP]4[/SUP], Mirza S[SUP]5[/SUP], Lafond KE[SUP]5[/SUP], McCarron M[SUP]5[/SUP], Corwin A[SUP]6[/SUP], Moen A[SUP]5[/SUP], Olsen SJ[SUP]5[/SUP], Bresee JS[SUP]7[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Despite global recommendations for influenza vaccination of high-risk, target populations, few low and middle-income countries have national influenza vaccination programs. Between 2012 and 2017, Lao PDR planned and conducted a series of activities to develop its national influenza vaccine program as a part of its overall national immunization program. In this paper, we review the underlying strategic planning for this process, and outline the sequence of activities, research studies, partnerships, and policy decisions that were required to build Laos' influenza vaccine program. The successful development and sustainability of the program in Laos offers lessons for other low and middle-income countries interested in initiating or expanding influenza immunization.
Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza; Laos; Policy; Vaccination program; Vaccine
PMID: 31027926 DOI: 10.1016/j.vaccine.2019.04.047
[TABLE="cellspacing: 1"]
[TR]
[TD="class: SL, width: 10%, align: right"][/TD]
[TD="class: SL, width: 20%, align: left"]Detect languageundefined[/TD]
[TD="class: SL, width: 3, align: center"]
[/TD]
[TD="class: SL, width: 20%, align: left"]undefined[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 15%, align: right"]
[/TD]
[/TR]
[/TABLE]
Text-to-speech function is limited to 200 characters